Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stride (LRN) Cash & Equivalents (2016 - 2025)

Stride (LRN) has disclosed Cash & Equivalents for 16 consecutive years, with $497.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 3.49% to $497.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $497.1 million, a 3.49% decrease, with the full-year FY2025 number at $782.5 million, up 56.31% from a year prior.
  • Cash & Equivalents was $497.1 million for Q4 2025 at Stride, down from $518.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $782.5 million in Q2 2025 to a low of $194.5 million in Q3 2022.
  • A 5-year average of $391.6 million and a median of $375.1 million in 2023 define the central range for Cash & Equivalents.
  • Biggest YoY gain for Cash & Equivalents was 119.3% in 2021; the steepest drop was 29.23% in 2021.
  • Stride's Cash & Equivalents stood at $257.0 million in 2021, then increased by 23.85% to $318.3 million in 2022, then increased by 11.34% to $354.4 million in 2023, then skyrocketed by 45.34% to $515.0 million in 2024, then fell by 3.49% to $497.1 million in 2025.
  • Per Business Quant, the three most recent readings for LRN's Cash & Equivalents are $497.1 million (Q4 2025), $518.4 million (Q3 2025), and $782.5 million (Q2 2025).